Adderall is a prescription stimulant approved to treat two conditions: attention deficit hyperactivity disorder (ADHD) and narcolepsy. It contains a mix of amphetamine salts that increase the activity of two chemical messengers in the brain, helping with focus, impulse control, and wakefulness. It’s one of the most widely prescribed ADHD medications in the United States, though ongoing supply shortages have made it harder to fill prescriptions in recent years.
How Adderall Works in the Brain
Adderall raises levels of two key brain chemicals: dopamine and norepinephrine. In people with ADHD, the part of the brain responsible for attention, planning, and impulse control (the prefrontal cortex) doesn’t process information as efficiently as it should. Norepinephrine helps strengthen important signals in that region, while dopamine reduces background “noise,” or irrelevant mental chatter. The combined effect sharpens focus and makes it easier to stay on task, sit still, and resist impulsive behavior.
This is why stimulants can seem paradoxical. A drug that speeds up brain activity actually helps people with ADHD feel calmer and more organized. It’s not sedating them; it’s giving their prefrontal cortex the chemical support it needs to work properly.
ADHD: The Primary Use
Most Adderall prescriptions are for ADHD, a condition marked by persistent inattention, hyperactivity, or impulsivity that interferes with daily functioning. In clinical trials, both Adderall and other stimulants significantly outperformed placebo in reducing ADHD symptoms as rated by parents, teachers, and clinicians. Adderall showed a particularly strong effect across the full range of improvement, meaning it helped patients achieve not just mild but substantial gains in functioning.
The medication comes in two forms. The immediate-release version (IR) lasts about four to six hours, so most people take it twice a day, once in the morning and once in the early afternoon. The extended-release version (XR) is designed to last eight to twelve hours with a single morning dose. Both contain the same active ingredients; the difference is how the pill releases them over time. Many adults and older teens prefer XR for the convenience, while IR can be useful when shorter, more flexible coverage is needed.
Narcolepsy: The Other Approved Use
Narcolepsy causes overwhelming daytime sleepiness that no amount of nighttime sleep fully resolves. People with narcolepsy may fall asleep suddenly during conversations, at work, or while driving. Amphetamine-based stimulants like Adderall have been a standard treatment for this excessive sleepiness for decades, and the American Academy of Sleep Medicine recognizes them as effective.
Finding the right dose for narcolepsy often takes time. Sleep specialists report that patients may need several months, sometimes up to a year, of adjusting medications and dosages before landing on what works. People with narcolepsy also tend to need higher doses than ADHD patients, partly because their tolerance for stimulants is unusually high. A dose that would feel overwhelming to someone without narcolepsy may barely keep a narcolepsy patient awake.
Off-Label Uses
Doctors sometimes prescribe Adderall for conditions it wasn’t specifically approved for. The two most common off-label uses with reasonable clinical support are treatment-resistant depression (particularly in older adults) and cognitive difficulties following a traumatic brain injury. In both cases, the stimulant effect can help with motivation, mental clarity, and energy when other treatments haven’t worked.
Less commonly, stimulants are prescribed for fatigue related to neurological conditions like multiple sclerosis, or for excessive daytime sleepiness when other wakefulness medications aren’t effective. Using Adderall for weight loss or cognitive “enhancement” in healthy people is generally not recommended by clinicians, even though these uses exist in practice.
Common Side Effects
The most frequent side effects in clinical trials were loss of appetite (22% of patients versus 2% on placebo), insomnia (17% versus 2%), and stomach pain (14% versus 10%). Nervousness, nausea, and vomiting were also more common than with placebo, though at lower rates. These side effects tend to be dose-dependent: in one trial, appetite loss jumped from about 16% at the lowest dose to nearly 27% at the highest, and insomnia followed a similar pattern.
Weight loss is a related concern, reported in about 4% of patients and rising with higher doses. Among children in longer trials, the side effects most likely to cause someone to stop taking the medication entirely were appetite loss (3.3%), insomnia (1.8%), weight loss (1.3%), and mood instability (1.1%).
Who Should Not Take It
Adderall is not safe for everyone. It’s contraindicated in people with symptomatic heart disease, moderate to severe high blood pressure, overactive thyroid, glaucoma, or a history of drug abuse. Anyone taking a type of antidepressant called an MAO inhibitor must wait at least 14 days after stopping it before starting Adderall, because the combination can cause a dangerous spike in blood pressure.
People with serious structural heart problems, abnormal heart rhythms, or coronary artery disease should generally avoid stimulants entirely. Even in otherwise healthy people, Adderall can raise blood pressure and heart rate modestly, which matters if you have an underlying cardiovascular condition. On the psychiatric side, stimulants can worsen psychotic symptoms, trigger manic episodes in people with bipolar disorder, aggravate tics or Tourette’s syndrome, and potentially lower the seizure threshold in people with epilepsy.
Controlled Substance Classification
Adderall is classified as a Schedule II controlled substance by the DEA, the same category as oxycodone and fentanyl. This means it has legitimate medical uses but also a high potential for abuse and dependence. In practical terms, this classification makes prescriptions harder to manage: you typically can’t get automatic refills, your doctor may need to write a new prescription each month, and pharmacies face strict limits on how much they can stock.
The Ongoing Shortage
If you’ve had trouble filling an Adderall prescription recently, you’re not alone. The immediate-release generic has been in shortage since at least 2022, and as of spring 2026 the problem persists. Multiple manufacturers have reported limited supply due to a combination of active ingredient delays, shipping disruptions, and surging demand. Several common dosage strengths, including 5 mg, 10 mg, 20 mg, and 30 mg tablets, remain on back order from various suppliers, with some companies unable to estimate when full supply will return. If your pharmacy can’t fill your prescription, calling around to other pharmacies, asking about alternative manufacturers, or discussing substitute medications with your prescriber are the most practical options.